Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Clinical trial NCT04561362 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04561362
Sponsor: BicycleTx Limited
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasm Triple Negative Breast Neoplasms Hormone Receptor Positive, HER2-negative Neoplasms Hormone Receptor Positive, HER2-low Neoplasms Breast Neoplasms Non-Small-Cell Lung Neoplasms Ovarian Neoplasm Advanced Solid Tumor

Start date: 2020-07-17
Primary completion: 2026-03-01
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.